| Paul A Colaiaco, MD | |
|
412 E Commons, East Commons Center, Pittsburgh, PA 15212-5310 | |
| (412) 442-1900 | |
| (412) 442-1901 |
| Full Name | Paul A Colaiaco |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 412 E Commons, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033108402 | NPI | - | NPPES |
| 128475 | Other | PA | HIGHMARK |
| 0990624 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD030866E (Pennsylvania) | Primary |
| Entity Name | Mercy Life Center Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720075104 PECOS PAC ID: 9335042514 Enrollment ID: O20040128000504 |
News Archive
Do blood vessels that feed tumors differ from other blood vessels? Fourteen years ago, experiments designed to answer that question led to the discovery of several genes that are more active in tumor-associated blood vessels than in normal blood vessels. New research now reveals the normal function of one of those genes and suggests it could be a good target for anticancer drug therapy.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that TF12, in combination with radiolabeled peptides, produced specific, fast, high-contrast imaging and pretargeted radioimmunotherapy of epithelial cancers that include cancers of the prostate and the ovary.
In a world first, pluripotent stem cells have been generated from horses by a team of researchers led by Dr. Andras Nagy at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital and Dr. Lawrence Smith at the University of Montreal's Faculty of Veterinary Science.
Using a genetically modified form of the HIV virus, a team of University of Nebraska-Lincoln scientists has developed a promising new approach that could someday lead to a more effective HIV vaccine.
The life of many individuals with inflammatory diseases such as rheumatoid arthritis has been dramatically improved by treatment with drugs that target the protein TNF, so called anti-TNF therapies.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul A Colaiaco, MD 1200 Reedsdale St, Pittsburgh, PA 15233-2109 Ph: (412) 323-4543 | Paul A Colaiaco, MD 412 E Commons, East Commons Center, Pittsburgh, PA 15212-5310 Ph: (412) 442-1900 |
News Archive
Do blood vessels that feed tumors differ from other blood vessels? Fourteen years ago, experiments designed to answer that question led to the discovery of several genes that are more active in tumor-associated blood vessels than in normal blood vessels. New research now reveals the normal function of one of those genes and suggests it could be a good target for anticancer drug therapy.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that TF12, in combination with radiolabeled peptides, produced specific, fast, high-contrast imaging and pretargeted radioimmunotherapy of epithelial cancers that include cancers of the prostate and the ovary.
In a world first, pluripotent stem cells have been generated from horses by a team of researchers led by Dr. Andras Nagy at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital and Dr. Lawrence Smith at the University of Montreal's Faculty of Veterinary Science.
Using a genetically modified form of the HIV virus, a team of University of Nebraska-Lincoln scientists has developed a promising new approach that could someday lead to a more effective HIV vaccine.
The life of many individuals with inflammatory diseases such as rheumatoid arthritis has been dramatically improved by treatment with drugs that target the protein TNF, so called anti-TNF therapies.
› Verified 6 days ago
Erek Lam, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9104 Babcock Blvd Ste 2116, Second Floor, Pittsburgh, PA 15237 Phone: 412-367-1003 | |
Kimberly Clinebell, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3811 Ohara St, Pittsburgh, PA 15213 Phone: 412-624-2100 | |
Kimberly Mathos, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 712 South Ave, Pittsburgh, PA 15221 Phone: 412-243-3400 | |
Dr. Melvin P Melnick, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 530 Marshall Ave., Pittsburgh, PA 15214 Phone: 412-442-2885 Fax: 412-322-5405 | |
Emil Ivanov, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3811 Ohara St, Pittsburgh, PA 15213 Phone: 412-246-6801 | |
Maria Baldwin, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3471 5th Ave, Kaufmann Bldg. Suite 810, Pittsburgh, PA 15213 Phone: 412-692-4920 Fax: 412-692-4907 | |
Dr. Claire M Cohen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2575 Boyce Plaza Rd, Pittsburgh, PA 15241 Phone: 412-257-2290 Fax: 412-206-0217 |